You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股消息》生科企(方土方)博醫療申請上市 傳籌3億美元
阿思達克 05-11 16:42
生物科技公司(方土方)博醫療向聯交所提交主板上市申請,聯席保薦人為高盛及海通國際。據路透旗下IFR引述消息指,(方土方)博目標集資約3億美元。

初步招股文件指,該公司專注於介入性肺病學領域,在中國和全球範圍內提供創新型肺部疾病解決方案,包括全肺抵達虛擬導航技術,核心產品為用於治療慢性阻塞性肺病和肺癌的治療設備InterVapor。

截至去年底止年度,公司錄得收入325.9萬美元,按年下跌59.6%,年內虧損擴大至4,878.6萬美元,較2019年同期的3,255.1萬美元增加。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account